Pfizer Vaccine for Children 5 to 11 is Safe with Robust Antibody Response
September 23, 2021
A Phase 2/3 trial conducted by Pfizer and BioNTech revealed that the Covid-19 vaccine was safe and generated a “robust antibody response” in children ages 5 to 11.